CORVEL CORP (CRVL)
Health Care / Health Care Services
S&P SmallCap 600$54.15
Scores poorly across most models. Proceed with caution.
Weak
Score based on 2 of 5 models — limited data
Is CORVEL CORP a Good Investment in 2026?
CORVEL CORP (CRVL) scores 3.8 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Piotroski model rates CORVEL CORP as Strong (7/9). However, the Graham model rates it Caution — Significantly above fair value. CORVEL CORP currently trades above its estimated fair value of $41, suggesting limited upside at current prices. CORVEL CORP ranks #888 out of 1127 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Estimated Fair Value
Trading above estimated fair value — the market may be pricing in future growth.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
7/9
Buffett
Limited Data
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Limited Data
Earnings yield + return on capital
Frequently Asked Questions
Is CORVEL CORP (CRVL) a good investment?
What is CORVEL CORP's Piotroski F-Score?
Is CRVL overvalued or undervalued?
How does CRVL compare to other Health Care stocks?
What do investment models say about CRVL?
Similar Stocks
Compare CRVL with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer